NCT01679691

Brief Summary

Epidural anesthesia is a very useful tool in lower limb salvage surgery, which helps pain control intra and more importantly post-operative pain. It is a well-known effect of epidural injections to cause a sympathetic stimulation and consequently vasodilatation in the lower limb vessels. Since epidural catheters can cause vasodilatation in lower limb vessels, they can subsequently lead to increased intra and post-operative bleeding from the surgical wound. The study will involve all patients having a bone tumor in the lower limb and subjected to tumor resection and reconstruction by prosthesis. The patient will be randomized according to the administration of epidural anesthesia into two arms, an arm in which epidural anesthesia was employed and another arm in which the patient was subjected only to general anesthesia and the amount of intra and postoperative bleeding will be compared in both arms.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2012

Completed
25 days until next milestone

First Posted

Study publicly available on registry

September 6, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 17, 2018

Status Verified

April 1, 2018

Enrollment Period

5 years

First QC Date

August 12, 2012

Last Update Submit

April 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measure the blood loss intra- and post-operative in both the contro and study groups

    The amount of blood loss will be assessed using: * Intra-operative: measurement of dressing before and after being soaked. * Post-operative: amount of blood drainage and duration of use of the suction drain.

    start of surgery until removal of sucction drain

Secondary Outcomes (1)

  • prolongation of hospital stay

    the number of days calculated from date of surgery until dischare from hospital expected average from 5 to 7 days

Study Arms (2)

Control group

NO INTERVENTION

Control group in whom no epidural anesthesia will be applied

Epidural Anesthesia

ACTIVE COMPARATOR

the group in whom all patients will be subjected to epidural anesthesia intra- and post-operative

Other: epidural anesthesia

Interventions

the group in whom all patients will be subjected to epidural anesthesia intra- and post-operative

Epidural Anesthesia

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • lower limb bone tumor
  • reconstruction by prosthesis

You may not qualify if:

  • upper limb and pelvic salvage surgery.
  • other methods of reconstruction than prosthesis
  • use of tourniquet intra-operative.
  • post-operative anticoagulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Cancer Hospital Egypt-57357

Cairo, 11441, Egypt

Location

MeSH Terms

Conditions

Bone Neoplasms

Interventions

Anesthesia, Epidural

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • ahmed elghoneimy, MD

    Children's Cancer Hospital Egypt 57357

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2012

First Posted

September 6, 2012

Study Start

September 1, 2011

Primary Completion

September 1, 2016

Study Completion

December 1, 2016

Last Updated

April 17, 2018

Record last verified: 2018-04

Locations